COMMERCIALIZATION
World-changing solutions.
Amplified impact.
SRI’s investment, innovation, partnership, and product professionals work with federal and commercial clients to inform and accelerate deep-tech innovation through commercial R&D, IP licensing, startup support, and so much more.
Innovating in
13,000+patents filed
100+active licenses
$4B+federal funding(past 10 years)
30+startups in portfolio
“You may know SRI for its unparalleled research legacy in Silicon Valley and throughout the U.S. But how we take this bold portfolio of innovation to market will define the impact SRI will have in the next half a century.”
Suresh SunderrajanPresident, Commercialization
How we work
Here’s how we work with visionaries to bring ideas to fruition — and to market.
Real-world impact
-
Podcast: Supporting and empowering STEM students in community college
SRI’s Andrea Beesley and Carol Tate discuss a national initiative aimed at supporting underrepresented students.
-
The naked mole rat may hold the key to new treatments for neurodegenerative diseases
SRI researchers study the cells of the long-living rodent to find new drug targets for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.
-
Engineered helper T cell could become a cancer killer
SRI scientists are developing a cell-based platform using an often-undervalued subset of helper T cells to deliver potent antitumor proteins for solid tumors, overcoming dose-related toxicities.